#techpapersworld - Techseriesinsight

January 19, 2026
tsi_admin
Insights

Next-Gen Measurement: Moving Beyond Last-Click to Experience Scores & Revenue Impact

For years, last-click attribution has been the comfort blanket of digital measurement. It’s simple, deterministic, and easy to explain in a dashboard review. But in a world of fragmented...

January 19, 2026
Business Wire
Biotechnology, News

Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform

A leading precision oncology company, today announced a multi-year collaboration with Merck, known as MSD outside the United States and Canada, to support the development and commercialization of Merck’s...

January 19, 2026
Business Wire
Artificial Intelligence, News

Alexi Files Counterclaims Against Clio and vLex; Alleges $1B Merger Created Unlawful “Clog on Competition

A pioneer in AI-powered legal research, has filed counterclaims in federal court against Themis Solutions Inc. (Clio), vLex, and Fastcase. The filing alleges that Clio is leveraging its recent...

January 19, 2026
PRNewswire
Analytics, News

Kaizen Analytix Strengthens Japan-India Delivery Model with Nihon Acquisition

Kaizen Analytix, a global provider of AI, data analytics, and technology services, today announced the acquisition of Nihon Technology, an IT services company specializing in SAP implementation, Digital Transformation, and...

January 19, 2026
PRNewswire
Artificial Intelligence, News

Anduril Selects Dirac to Power AI-Driven Work Instructions Across Its Factories

Anduril has selected Dirac as its core partner for AI-driven work instruction authoring across its manufacturing operations in a multi-year deal, following an extensive evaluation of incumbent enterprise solutions...

January 19, 2026
Business Wire
Biotechnology, News

ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) in combination with pertuzumab for the first-line treatment of adult patients with...

January 19, 2026
PRNewswire
Cloud, News

IBM Launches Enterprise Advantage Service to Help Businesses Scale Agentic AI

Today announced IBM Enterprise Advantage, a first-of-its-kind asset-based consulting service that combines proven AI-tools and expertise to help clients quickly build, govern, and operate their own tailored internal AI...

January 19, 2026
PRNewswire
Artificial Intelligence, News

More than two-thirds of investment managers prominently using AI to support front office, SimCorp study reveals

70 percent of buy-side firms are successfully employing Artificial Intelligence to support their front office, according to a new global study commissioned by SimCorp, a global leader in financial...

January 19, 2026
PRNewswire
Healthcare, News

Akeso Announces NMPA Acceptance of Second NDA for Gumokimab in Active Ankylosing Spondylitis

Announced that its supplemental New Drug Application (sNDA) for gumokimab (AK111), a novel humanized anti-IL-17A monoclonal antibody for the treatment of active ankylosing spondylitis (AS), has been accepted for...

January 19, 2026
Business Wire
Biotechnology, News

Median Technologies Reports Landmark 2025 Performance With Major Regulatory and Commercial Milestones Ahead in 2026

Median Technologies, manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based...